Takeda
TAKHZYRO
Manufacturer:
Takeda
Name:
TAKHZYRO
HCPCS Code Descriptor:
Injection, lanadelumab-flyo, 1 mg (code may be used for medicare when drug administered under direct supervision of a physician, not for use when drug is self-administered)
Category:
J Code
HCPCS:
J0593
NDC(s):
47783-0646-01, 47783-0645-01, 47783-0644-01
Primary Type:
Immunology
Generic Status:
Single-Source
Route of Administration:
Subcutaneous
About:
TAKHZYRO is an Immunology drug manufactured by Takeda and administered via the Subcutaneous route of administration. The J Code: J0593 is aligned to the drug TAKHZYRO.